Article
Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial.
Journal of clinical microbiology - 1 Aug 2011
Friedrich Sven O, Venter Amour, Kayigire Xavier A, Dawson Rodney, Donald Peter R, Diacon Andreas H
Abstract excerpt
Participation criteria for clinical trials in pulmonary tuberculosis commonly include confirmation of sputum positive for mycobacteria and an indication of drug susceptibility before treatment is initiated. We investigated the suitability of two novel sputum-based nucleic acid amplification methods for patient selection in a recent early bactericidal activity study. Spontaneously expectorated sputum samples of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
